Keywords: isentress, works, well, untreated, hiv, patients, drug

Isentress works well in untreated HIV patients

Article | 18 August 2008

Print This

US drug major Merck & Co's Isentress (raltegravir) in combination with two other HIV drugs reduced viral load to undetectable levels ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in